Kostas Tsioufis
Overview
Explore the profile of Kostas Tsioufis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chrysohoou C, Mantzouranis E, Dimitroglou Y, Mavroudis A, Tsioufis K
Nutrients
. 2022 Apr;
14(7).
PMID: 35405998
The main challenges in heart failure (HF) treatment are to manage patients with refractory acute decompensated HF and to stabilize the clinical status of a patient with chronic heart failure....
12.
Latsios G, Synetos A, Leopoulou M, Stamatopoulou E, Koukopoulos P, Parisis C, et al.
Open Access Emerg Med
. 2022 Feb;
14:63-75.
PMID: 35210874
Objective: The aim of this study was to evaluate the level of established knowledge regarding cardiopulmonary resuscitation (CPR) during the pre-vaccine Covid-19 pandemic era of certified Basic Life Support (BLS)...
13.
Sagris M, Theofilis P, Antonopoulos A, Oikonomou E, Tsioufis K, Tousoulis D
Biomedicines
. 2022 Feb;
10(2).
PMID: 35203452
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and the resulting coronavirus disease-19 (COVID-19) have led to a global pandemic associated with high fatality rates. COVID-19 primarily manifests in the respiratory system...
14.
Fici F, Faikoglu G, Tarim B, Robles N, Tsioufis K, Grassi G, et al.
High Blood Press Cardiovasc Prev
. 2022 Jan;
29(2):137-144.
PMID: 35064911
Stains remain the first therapeutic approach in patients with dyslipidemia to control plasma lipids levels and cardiovascular risk. Multiple clinical trials have demonstrated the benefits of statins in reducing major...
15.
Sagris M, Theofilis P, Antonopoulos A, Oikonomou E, Paschaliori C, Galiatsatos N, et al.
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34948272
Chronic low-grade inflammation is involved in coronary atherosclerosis, presenting multiple clinical manifestations ranging from asymptomatic to stable angina, acute coronary syndrome, heart failure and sudden cardiac death. Coronary microvasculature consists...
16.
Maragkoudakis S, Marketou M, Katsi V, Patrianakos A, Tsigkriki L, Mamaloukaki M, et al.
Arch Med Sci Atheroscler Dis
. 2021 Oct;
6:e176-e181.
PMID: 34703947
Introduction: Heart failure (HF) with reduced ejection fraction (HFrEF) remains a challenging problem due to its high mortality rate. The PARADIGM HF trial and a new class of drugs -...
17.
Latsios G, Synetos A, Leopoulou M, Stamatopoulou E, Vogiatzi G, Parisis C, et al.
Hellenic J Cardiol
. 2021 Apr;
63:82-85.
PMID: 33845202
No abstract available.
18.
Aggeli C, Polytarchou K, Dimitroglou Y, Patsourakos D, Delicou S, Vassilopoulou S, et al.
J Thromb Thrombolysis
. 2021 Feb;
52(3):889-897.
PMID: 33638018
Sickle cell disease (SCD) is an inherited monogenic hemoglobinopathy characterized by formation of sickle erythrocytes under conditions of deoxygenation. Sickle erythrocytes can lead to thrombus formation and vaso-occlusive episodes that...
19.
Kotsis V, Jordan J, Stabouli S, Antza C, Micic D, Jelakovic B, et al.
J Hypertens
. 2019 Nov;
38(3):377-386.
PMID: 31764586
: The prevalence of type 2 diabetes (T2D) has increased over the past few decades. T2D has a strong genetic propensity that becomes overt when a patient is exposed to...
20.
Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, et al.
Curr Hypertens Rev
. 2019 Apr;
16(1):19-23.
PMID: 30987572
Background: Primary aldosteronism is one of the most common causes of secondary hypertension. Patients with this endocrine syndrome are at increased cardiovascular risk, higher than hypertensive individuals with equal blood...